Asset Search
Displaying assets 2911 - 2940 of 2002571 in total. Search results limited to 100 out of 66753 pages. Please refine your search query.
-
Description Response characteristics
-
Description Respondent characteristics
-
Description Prevalence and 95% confidence intervals for asthma and respiratory symptoms for Melbourne and the Riverina
-
Description Significant independent risk factors for reporting respiratory symptoms and asthma from both centres combined (n = 6300). Odds ratios (OR) and 95% confidence intervals estimated by multiple...
-
Description Monthly rates of hospitalizations (1978–1995) and deaths (1976–1995) due to asthma in New Zealand
-
Description General characteristics and baseline clinical data
-
Description Admission rates of magnesium sulfate and placebo groups
-
Description Analysis of variance table on severity score of magnesium sulfate and placebo group
-
Description Demographic data (safety population)
-
Description Patients discontinuing from the study (entry population)
-
Description Overall safety of twice‐daily budesonide in the treatment of Japanese mild‐to‐moderate asthmatics (safety population)
-
Description Causes of 255 pleural effusions
-
Description Summary of statistical results
-
Description Aetiology of pleural effusions among 87 patients
-
Description Pleural fluid and serum total adenosine deaminase (ADA), ADA1 and ADA2 activities in each group
-
Description Pleural fluid and serum total adenosine deaminase (ADA), ADA1 and ADA2 activities and diagnostic values between the tuberculous and non‐tuberculous group
-
Description Five cases of tracheobronchopathia osteochondroplastica reported in the Turkish literature
-
Description Effect of endothelin antagonists on magnitude of the response** and the potency† of endothelin‐1 in rabbit isolated bronchus
-
Description Effect of endothelinA and endothelinB receptor antagonism on the potentiation of the response† to electrical field stimulation by endothelin‐3 in rabbit isolated bronchus
-
Description Demographic characteristics of lung cancer patients
-
Description Clinicopathological differences between younger and older lung cancer patients
-
Description Relationship between smoking and main lung cancer cell types in younger and older patients
-
Description Clinicopathological differences between younger and older lung cancer patients according to gender
-
Description Treatment for lung cancer in younger and older patients
-
Description Ranges and data sources of sensitivities and specificities for the different diagnostic approaches tested in sensitivity analyses
-
Description Costs, mortalities and their data sources used in the decision model
-
Description The actual disease incidence in sub‐groups of patients with different pretest probabilities of PTB
-
Description Changes in bronchoscopic findings of 34 actively caseating endobronchial tuberculosis during treatment
-
Description Changes in bronchoscopic findings of 11 oedematous–hyperaemic endobronchial tuberculosis during treatment
-
Description Changes in bronchoscopic findings of 10 tumorous endobronchial tuberculosis during treatment
Displaying assets 2911 - 2940 of 2002571 in total. Search results limited to 100 out of 66753 pages. Please refine your search query.